No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.
about
A perspective on the role of estrogen in hormone-induced prostate carcinogenesisSERPING1 polymorphisms in polypoidal choroidal vasculopathy.Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publicationsGenetic variation: effect on prostate cancer.The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.Hormones and prostate carcinogenesis: Androgens and estrogens.SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.Erectile dysfunction and the risk of prostate cancer.Sample size in pilot genetic studies.Systematic biochemical analysis of somatic missense mutations in DNA polymerase β found in prostate cancer reveal alteration of enzymatic functionSteroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.Correcting for differential genotyping error in genetic association analysis.
P2860
Q27004552-07A4D001-8781-4D65-8E7A-D333AF8CBF76Q33655831-2E88F76B-3820-4086-96C5-CB76864BAB2DQ33672581-CE911E99-3F1E-438F-B580-817E8D889891Q34663656-FB517612-3E7B-4D23-BE66-0B624ABDC02DQ34962430-CBBCBA0D-F8B0-418A-B200-E89F14D264D7Q35687198-1715BEB7-57D0-43CE-980C-C45E88D4832CQ37343506-A5061D1E-B8EE-4BB9-8583-004D493BAF0FQ37633264-4EB72C51-EEFE-4291-A780-EFBB4AFE9A33Q40309735-456E9A90-2CDF-43DC-BC1C-EAD98BB5AB63Q40474024-36059582-A767-46EF-9B7A-EBDA4334B34DQ41592854-8BC735E9-9A3C-42D5-BB01-B20749A5678FQ42252922-1422EC51-6119-4FB9-80E8-9006C85B7622Q42700256-59B69ABD-A3BF-4C56-8179-FE89CB64BFC8Q43595675-0CA19DAA-7A03-46C7-B7AF-D49D9860B8BCQ46259406-5D399A78-EB0D-45A5-A530-0B56193A2338
P2860
No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
No association between the SRD ...... cancer risk: lessons learned.
@en
No association between the SRD ...... cancer risk: lessons learned.
@nl
type
label
No association between the SRD ...... cancer risk: lessons learned.
@en
No association between the SRD ...... cancer risk: lessons learned.
@nl
prefLabel
No association between the SRD ...... cancer risk: lessons learned.
@en
No association between the SRD ...... cancer risk: lessons learned.
@nl
P2093
P2860
P356
P1476
No association between the SRD ...... cancer risk: lessons learned.
@en
P2093
C Leigh Pearce
David J Van Den Berg
Laurence N Kolonel
Malcolm C Pike
Nick Makridakis
Ronald K Ross
P2860
P304
P356
10.1093/HMG/DDN145
P577
2008-05-10T00:00:00Z